DiaMedica to Present at the 14th Annual Noble Investor Conference
January 29 2018 - 8:45AM
DiaMedica Therapeutics Inc. (TSXV:DMA) (OTCQB:DMCAF), today
announced that Mr. Rick Pauls, its President and CEO, will present
at Noble Capital Markets’ Fourteenth Annual Investor Conference at
the W Hotel, Fort Lauderdale, Florida on
Tuesday, January
30th at 01:30 pm EST - Studio 1.
About DiaMedica Therapeutics:
DiaMedica Therapeutics is a clinical stage biopharmaceutical
company focused on developing novel treatments for neurological and
kidney diseases. DiaMedica’s shares are listed on the TSX Venture
Exchange under the trading symbol “DMA” and on the OTCQB under the
trading symbol “DMCAF”.
DiaMedica’s lead product candidate DM199, a recombinant
(synthetic) form of the KLK1 protein, is in development for the
treatment of neurological and kidney diseases.
For more information, please
visit www.diamedica.com. Follow us on social
media
- Twitter, LinkedIn.
About Noble Capital Markets, Inc.
Noble Capital Markets, established in 1984, is an
equity-research driven, full-service, investment & merchant
banking boutique focused on the healthcare, media &
entertainment, technology, transportation & logistics and
natural resources sectors. The company has offices in Boca Raton,
New York and Boston and St. Louis. In addition to NobleCon - the
annual multi-sector investor conference - and the Media, Finance
& Investor Program - produced in partnership with the National
Association of Broadcasters (NAB) and held each spring in Las Vegas
- Noble hosts numerous “non-deal” corporate road shows throughout
the year across the United States and Canada. Members: FINRA, SIPC,
MSRB. www.noblecapitalmarkets.com
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of the contents of this press release.
For further information, please contact:Paul
Papi Vice President of Business Development DiaMedica Therapeutics
Inc. Two Carlson Parkway, Suite 260 Minneapolis, MN Phone: (617)
899-5941 info@diamedica.com
Tweet this!
DiaMedica Inc. (TSXV:DMA)
Historical Stock Chart
From Oct 2024 to Nov 2024
DiaMedica Inc. (TSXV:DMA)
Historical Stock Chart
From Nov 2023 to Nov 2024